IDORSIA PHARMACEUTICALS LTD
Patent Owner
Stats
- 101 US PATENTS IN FORCE
- 6 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 101 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 760 Total Citation Count
- Feb 24, 2003 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0305,927 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTIONOct 14, 15Oct 26, 17[A61K, C07D]
2017/0129,884 AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORSMar 17, 15May 11, 17[C07D]
2016/0213,851 DOSING APPRATUS FOR DISPENSING A FLUID UNDER ASEPTIC CONDITIONSJan 26, 16Jul 28, 16[A61J, A61B, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9914720 Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonistsDec 02, 14Mar 13, 18[A61K, C07D]
9850241 Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsMar 17, 15Dec 26, 17[A61K, C07D]
9850256 Antibacterial basic biaromatic derivatives with aminoalkoxy substitutionOct 14, 15Dec 26, 17[A61K, C07D]
9790208 Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistDec 02, 14Oct 17, 17[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.